This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...

Parallel imports have been treated very differently in different countries. In the EU, competition law's very strong (per se) prohibition of restrictions to parallel imports (PI) can be justified by traditional "public interest" concerns related to the EU's objective to promote free trade and...

Die Frage der Zulassung von Parallelimporten von patentierten Gütern wird in der Schweiz kontrovers diskutiert. Medikamente stellen dabei einen Spezialfall der Güter mit Patentschutz dar, da die Preise für Medikamente in allen westlichen Ländern durch staatliche Behörden direkt oder...